Medicine Man Technologies logo

Medicine Man Technologies(OTC) SHWZ

Market Cap$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-100%
5 Year-100%
1 Year-90%
1 Month-100%
$0.00
+0.00%
+0.00Today
Medicine Man Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-29
Medicine Man Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+900%USD 0.002026-09-15
1 month-99.5%USD 0.002026-08-11
3 month+900%USD 0.002026-06-30
Year to date+900%USD 0.002025-12-31
1 year-90%USD 0.002025-09-29
3 year-100%USD 0.792023-09-29
5 year-100%USD 1.782021-09-30
Since inception-100%USD 3.162016-01-25

Medicine Man Technologies Financials at a Glance

Market Cap

$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$174.91M

Net Income (TTM)

-$59.68M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

680.46 (High)

Price

$0.00

Volume

588,805

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Aug 31, 2026

SHWZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medicine Man Technologies

Medicine Man Technologies, Inc. operates as a leading cannabis enterprise with a focus on retail, wholesale, and ancillary services. The company offers a diverse range of cannabis products and has established a significant presence in the Colorado and New Mexico markets.

Products and Services
  • Retail cannabis dispensaries under various brand names
  • Wholesale distribution of cannabis products and plant nutrients
  • Consulting and facility design services for cannabis operations
Growth Outlook
  • Revenue of $43.24 million in Q2 2024, showing strong market demand
  • Gross profit margin of 44% indicates effective cost management
  • Expansion plans in retail and wholesale segments to capture market share
Financial Highlights
  • Net income of -$13.94 million in Q2 2024, reflecting ongoing investment in growth
  • Operating income of -$2.74 million, with a focus on improving profitability
  • Cash and cash equivalents of $12.27 million, providing liquidity for operations
Medicine Man Technologies, Inc. has positioned itself as a significant player in the cannabis industry, leveraging its extensive product offerings and retail presence. The company operates 23 recreational dispensaries in Colorado and 10 medical dispensaries in New Mexico, catering to a growing customer base. Recent financial performance indicates a robust revenue stream, with Q2 2024 revenue reaching $43.24 million, a testament to the company's market penetration and brand recognition. Despite reporting a net loss, the gross profit margin of 44% highlights the company's ability to manage costs effectively while pursuing growth opportunities. The focus on expanding retail and wholesale operations is expected to enhance revenue potential and market share. With a solid cash position, Medicine Man Technologies, Inc. is well-equipped to navigate the evolving cannabis landscape and capitalize on emerging opportunities.
AI Generated • Sep 20, 2026

Industry

Pharmaceuticals

Employees

729

CEO

Nirup Krishnamurthy, PhD

Headquarters

Denver, CO 80220, US

SHWZ Financials

Key Financial Metrics (TTM)

Gross Margin

44.09%

Operating Margin

1.91%

Net Income Margin

-20.03%

Return on Equity

-27.48%

Return on Capital

1.06%

Return on Assets

-9.65%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

86.53M

Volume

588.80K

Avg. Volume

11.04K

Financials (TTM)

Gross Profit

$56.31M

Operating Income

-$12.77M

EBITDA

$12.79M

Operating Cash Flow

$6.59M

Capital Expenditure

-$8.06M

Free Cash Flow

-$1.47M

Cash & ST Invst.

$12.39M

Total Debt

$198.19M

Medicine Man Technologies Performance Analysis

Medicine Man Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 108,420,239N/A
20222022-12-31USD 159,379,21947.0%
20232023-12-31USD 172,447,7868.2%
Medicine Man Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-3010.3%
Q42023-12-31-7.3%
Q12024-03-31-4.0%
Q22024-06-303.9%
Medicine Man Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.06N/A
20222022-12-31USD -0.49787.3%
20232023-12-31USD -0.6635.1%
Medicine Man Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-3096.6%
Q42023-12-31-11791.9%
Q12024-03-3145.5%
Q22024-06-3016.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$43.24M

+2.0%

Gross Profit

$19.04M

-22.3%

Gross Margin

44.05%

N/A

Market Cap

$900.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.23

N/A

Employees

729

N/A

Net Income

-$13.94M

-110.9%

EBITDA

$4.29M

-61.3%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$12.39M

-39.1%

Total Debt

$198.19M

+9.2%

Accounts Receivable

$3.53M

-42.9%

Inventory

$24.87M

-26.5%

Long Term Debt

$163.52M

-4.4%

Short Term Debt

$34.67M

+226.8%

Return on Assets

-9.65%

N/A

Return on Invested Capital

1.09%

N/A

Free Cash Flow

-$724.79K

-181.2%

Operating Cash Flow

-$108.35K

-104.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LOWLFLowell Farms Inc.
$0.00+0.00%
FFNTF4Front Ventures Corp.
$0.00+0.00%
AYRWFAyr Wellness Inc.
$0.00+0.00%
CNTMFFluent Corp.
$0.02-5.21%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About SHWZ

What is the current price of Medicine Man Technologies?

Medicine Man Technologies is trading at $0.00 per share.

What is the 52-week range for Medicine Man Technologies?

Over the past 52 weeks, Medicine Man Technologies has traded between $0.00 and $0.01.

How much debt does Medicine Man Technologies have?

As of the most recent reporting period, Medicine Man Technologies reported total debt of $191.87M.

How much cash does Medicine Man Technologies have on hand?

Medicine Man Technologies reported $19.25M in cash and cash equivalents in its most recent financial results.

What is Medicine Man Technologies’s dividend yield?

Medicine Man Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.